|
|
Association of novel mutations and heplotypes
in the preS region of hepatitis B virus with hepatocellular carcinoma |
Jia-Xin XIE1,Jian-Hua YIN1,Qi ZHANG1,Rui PU1,Wen-Ying LU1,Hong-Wei ZHANG1,Guang-Wen CAO1,Jun ZHAO2,Hong-Yang WANG3, |
1.Department of Epidemiology,
Second Military Medical University, Shanghai 200433, China; 2.Department of Hepatobiliary
Surgery, the 3rd Affiliated Hospital, Second Military Medical University,
Shanghai 200433, China; 3.International Laboratory
for Signal Transduction, the 3rd Affiliated Hospital, Second Military
Medical University, Shanghai 200433, China; |
|
|
Abstract The association of viral mutations and haplotypic carriages with mutations in the preS region of hepatitis B virus (HBV) genotypes B and C with hepatocellular carcinoma (HCC) is of great significance for the prediction of this malignancy, but it remains obscure. We analyzed the preS sequences of HBV genotypes B and C from 1172 HBV-infected subjects including 231 patients with HCC. As compared with the HBV-infected subjects without HCC, C2875T, G2946C, A3054C, C3060A, T3066C, C3116T, A3120C, G3191A, A1C, C7A, C10A, A31C, C76T, G105C, and G147C in both genotypes were significantly associated with increased risks of HCC. C2875A, G2950A, G2951A, A3054T, C3060T, T3066A, T3069G, A3120T, and G3191C were significantly associated with increased risks of HCC in genotype C, whereas these mutations were inversely associated with HCC in genotype B. Multivariate regression analyses showed that C76A/T was a novel factor independently associated with an increased risk of HCC, as compared with those without HCC. The frequencies of haplotypes 2964A-3116T-preS2 start codon wild-type-7C, 2964C-3116T-7A-76C, and 2964A-3116T-7C-76A/T were significantly higher in the patients with HCC (P<0.001), whereas a haplotypic carriage with a single mutation and another three wild-types were inversely associated with HCC. Conclusively, the association of HBV mutations in the preS region with HCC depends on HBV genotype and haplotypic carriage with two or more mutations that are each associated with an increased risk of HCC independently.
|
Keywords
hepatitis B virus
hepatocellular carcinoma
mutation
genotype
haplotype
|
Issue Date: 05 December 2010
|
|
|
Nguyen V T, Law M G, Dore G J. Hepatitis B-related hepatocellular carcinoma:epidemiological characteristics and disease burden. J Viral Hepat, 2009, 16(7): 453–463 PMID: 19302335
|
|
El-Serag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132(7): 2557–2576 PMID: 17570226
|
|
Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellularcarcinoma: compared with chronic hepatitis B and asymptomatic carrierstate in the same area. Carcinogenesis, 2008, 29(9): 1685–1691 PMID: 18192693
|
|
Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virusmutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst, 2009, 101(15): 1066–1082 PMID: 19574418
|
|
Cao G W. Clinical relevance and public health significance ofhepatitis B virus genomic variations. World J Gastroenterol, 2009, 15(46): 5761–5769 PMID: 19998495
|
|
Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and hepatocellularcarcinoma-related viral properties of hepatitis B virus genotypesin Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev, 2010, 19(3): 777–786 PMID: 20160279
|
|
Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res, 2007, 127(2): 164–176 PMID: 17383765
|
|
Chen B F, Liu C J, Jow G M, Chen P J, Kao J H, Chen D S. High prevalence and mapping of pre-S deletion in hepatitisB virus carriers with progressive liver diseases. Gastroenterology, 2006, 130(4): 1153–1168 PMID: 16618410
|
|
Gao Z Y, Li T, Wang J, Du J M, Li Y J, Li J, Lu F M, Zhuang H. Mutations in preS genes of genotype Chepatitis B virus in patients with chronic hepatitis B and hepatocellularcarcinoma. J Gastroenterol, 2007, 42(9): 761–768 PMID: 17876546
|
|
Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation andits association with hepatocellular carcinoma in Qidong, China. Arch Virol, 2008, 153(10): 1807–1812 PMID: 18726170
|
|
Fang Z L, Sabin C A, Dong B Q, Wei S C, Chen Q Y, Fang K X, Yang J Y, Huang J, Wang X Y, Harrison T J. Hepatitis B virus pre-S deletionmutations are a risk factor for hepatocellular carcinoma: a matchednested case-control study. J Gen Virol, 2008, 89(Pt 11): 2882–2890 PMID: 18931087
|
|
Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosisor hepatocellular carcinoma. J Gastroenterol, 2010, 45(10): 1063–1071 PMID: 20419326
|
|
Chen J, Yin J, Tan X, Zhang H, Zhang H, Chen B, Chang W, Schaefer S, Cao G. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypesB1, B2, C1 and C2. J Clin Virol, 2007, 38(3): 238–243 PMID: 17224304
|
|
Zhang H W, Yin J H, Li Y T, Li C Z, Ren H, Gu C Y, Wu H Y, Liang X S, Zhang P, Zhao J F, Tan X J, Lu W, Schaefer S, Cao G W. Risk factors for acute hepatitis B and its progression to chronichepatitis in Shanghai, China. Gut, 2008, 57(12): 1713–1720 PMID: 18755887
|
|
Shen T, Yan X M, Zou Y L, Gao J M, Dong H. Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission. World J Gastroenterol, 2008, 14(37): 5674–5682 PMID: 18837083
|
|
Bock C T, Tillmann H L, Maschek H J, Manns M P, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infectionleads to virus retention and misassembly. Gastroenterology, 1997, 113(6): 1976–1982 PMID: 9394738
|
|
Hsieh Y H, Su I J, Wang H C, Chang W W, Lei H Y, Lai M D, Chang W T, Huang W. Pre-S mutant surface antigens in chronichepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis, 2004, 25(10): 2023–2032 PMID: 15180947
|
|
Kekulé A S, Lauer U, Meyer M, Caselmann W H, Hofschneider P H, Koshy R. The preS2/S region of integratedhepatitis B virus DNA encodes a transcriptional transactivator. Nature, 1990, 343(6257): 457–461 PMID: 2153938
|
|
G?bel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, Kneidinger D, Mühlbacher C, Bieglmayer C, Elbe-Bürger A, Strobl H. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic celldifferentiation. Blood, 2009, 114(18): 3813–3821 PMID: 19721012
|
|
Andrieux L O, Fautrel A, Bessard A, Guillouzo A, Baffet G, Langou?t S. GATA-1 is essential in EGF-mediatedinduction of nucleotide excision repair activity and ERCC1 expressionthrough ERK2 in human hepatoma cells. Cancer Res, 2007, 67(5): 2114–2123 PMID: 17332341
|
|
Banerjee R, Caruccio L, Zhang Y J, McKercher S, Santella R M. Effects of carcinogen-induced transcription factors on the activationof hepatitis B virus expression in human hepatoblastoma HepG2 cellsand its implication on hepatocellular carcinomas. Hepatology, 2000, 32(2): 367–374 PMID: 10915744
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|